Search

Author/Creator Cohen, Roger B

1. A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer. (6th November 2014)

Authors:
Cohen, Roger B; Nemunaitis, John; Gabrail, Nashat; Bazhenova, Lyudmila; Schreiber, Taylor H; Price, Melissa
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial. Issue 4 (12th April 2022)

Authors:
Aggarwal, Charu; Prawira, Amy; Antonia, Scott; Rahma, Osama; Tolcher, Anthony; Cohen, Roger B; Lou, Yanyan; Hauke, Ralph; Vogelzang, Nicholas; P Zandberg, Dan; Kalebasty, Arash Rezazadeh; Atkinson, Victoria; Adjei, Alex A; Seetharam, Mahesh; Birnbaum, Ariel; Weickhardt, Andrew; Ganju, Vinod; Josh...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. What if Acupuncture Were Covered by Insurance for Pain Management? A Cross-Sectional Study of Cancer Patients at One Academic Center and 11 Community Hospitals. Issue 10 (24th April 2019)

Authors:
Liou, Kevin T; Hung, Tony K W; Meghani, Salimah H; Epstein, Andrew S; Li, Q Susan; Romero, Sally A D; Cohen, Roger B; Mao, Jun J
Journal:
Pain medicine
Issue:
Volume 20:Issue 10(2019)
Page Start:
2060
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗